Diego Kyburz
Rheumatologe
Hat mitgewirkt an:
-
Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care
-
Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial
-
Plasma mtDNA as a possible contributor to and biomarker of inflammation in rheumatoid arthritis
-
Differential effects of specific cathepsin S inhibition in biocompartments from patients with primary Sjögren syndrome